Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species
These data support that PTPN22 (show PTPN22 ELISA Kits) 1858C/T, PTPRJ 2965C/G and 1176 A/C polymorphisms and ACP1 A (show ACP1 ELISA Kits), B and C alleles are not associated with a higher risk of immune thrombocytopenia P in adults.
Loss of PTPRJ expression may predict an aggressive clinical course in ESCC patients.
The strongest association with frailty was observed in the Protein Tyrosine Phosphatase (show ACP1 ELISA Kits), Receptor type, J (PTPRJ) (rs1566729, P = 0.001372, beta = 0.09397) gene.
the combination of CD200 (show CD200 ELISA Kits) and CD148 may have a potential differential diagnostic value in leukemic B-CLPDs, especially between CLL and MCL (show FH ELISA Kits).
These results demonstrated Ptprj as a physiological enzyme that attenuates insulin (show INS ELISA Kits) signalling in vivo, and indicate that an inhibitor of Ptprj may be an insulin (show INS ELISA Kits)-sensitizing agent.
CD148 tyrosine phosphatase promotes e-cadherin (show CDH1 ELISA Kits) cell adhesion.
The studies suggest induction of MMP-9 (show MMP9 ELISA Kits) expression promoted by DEP-1 deficiency.
Moderate expression of DEP-1 was associated with the increased relapse.
C33A cells lacking PTPRJ had increased cell viability, growth, migration, G1-S transition, and 5-FU resistance. PTPRJ negatively regulated the JAK1 (show JAK1 ELISA Kits)/STAT3 (show STAT3 ELISA Kits) pathway by decreasing phosphorylation levels of JAK1 (show JAK1 ELISA Kits) and STAT3 (show STAT3 ELISA Kits) and expression of downstream factors.
The expression profiles of DEP1 and B2MG correlate with increased cell senescence and survival in breast cancer.
our results established DEP-1 as an essential driver of VEGF-dependent permeability, angiogenesis, and metastasis
DEP-1 acts as an endogenous antagonist of the insulin receptor (show INSR ELISA Kits), and downregulation of DEP-1 results in an improvement of insulin (show INS ELISA Kits) sensitivity.
Data indicate that CD148 mRNA is upregulated in diseased joints of with collagen-induced arthritis.
The large ectodomains of CD45 and CD148 modulate their inhibitory effect by enabling their passive, size-based segregation from ligated TCR, supporting the kinetic-segregation model of TCR triggering.
phosphatase CD148 promotes airway hyperresponsiveness through SRC (show SRC ELISA Kits) family kinases
These data indicate that PTPRJ may regulate differentiation of normal mammary epithelia and that dysregulation of protein localisation may be associated with tumorigenesis.
CD148 plays a dominant role in activating Src (show SRC ELISA Kits) family kinases in platelets relative to PTP-1B (show PTPN1 ELISA Kits). Both PTPs (show PTS ELISA Kits) are required for optimal platelet activation and aggregate formation under high arterial shear rates.
CD45 and CD148 preferentially target different SFK members (Hck and Fgr versus Lyn, respectively) to positively and negatively regulate GPCR pathways.
differential effects of CD148 in T cells and other leukocyte subsets
The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes, including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region containing five fibronectin type III repeats, a single transmembrane region, and a single intracytoplasmic catalytic domain, and thus represents a receptor-type PTP. This protein is present in all hematopoietic lineages, and was shown to negatively regulate T cell receptor signaling possibly through interfering with the phosphorylation of Phospholipase C Gamma 1 and Linker for Activation of T Cells. This protein can also dephosphorylate the PDGF beta receptor, and may be involved in UV-induced signal transduction. Multiple transcript variants encoding different isoforms have been found for this gene.
receptor-type tyrosine-protein phosphatase eta
, density enhanced phosphatase-1
, protein tyrosine phosphatase, receptor type, J
, receptor-type tyrosine-protein phosphatase eta-like
, CD148 antigen
, HPTP eta
, density-enhanced phosphatase 1
, human density enhanced phosphatase-1
, protein tyrosine phosphatase, receptor type, J polypeptide
, protein-tyrosine phosphatase eta
, protein-tyrosine phosphatase receptor type J
, susceptibility to colon cancer 1, mouse, homolog of
, HPTP beta-like tyrosine phosphatase
, colon tumor susceptibility 1
, susceptibility to colon cancer 1
, supporting-cell antigen